Dietary glycotoxins affect scavenger Receptor expression and the hormonal profile of female rats

Journal of Endocrinology

Volumn 218, Issue 3, 2013, Pages 331-337

  Chatzigeorgiou, Antonios ^a,b   Kandaraki, Eleni ^a   Piperi, Christina ^a   Livadas, Sarantis ^a   Papavassiliou, Athanasios G ^a   Koutsilieris, Michael ^a   Papalois, Apostolos ^c   Diamanti Kandarakis, Evanthia ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c ELPEN Pharmaceuticals   (Greece)

Author keywords

AGEs; Endocrine dysregulation; Insulin resistance; PCOS; Rage; SR A

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ESTRADIOL; GLUCOSE; GLYCOTOXIN; INSULIN; PROGESTERONE; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR A; TESTOSTERONE; TOXIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DIETARY INTAKE; DOWN REGULATION; ESTRADIOL BLOOD LEVEL; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HORMONAL REGULATION; HORMONE DETERMINATION; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; METABOLIC REGULATION; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN EXPRESSION; RAT; TESTOSTERONE BLOOD LEVEL;

AGES; ENDOCRINE DYSREGULATION; INSULIN RESISTANCE; PCOS; RAGE; SR-A;

ANIMALS; DIET; ESTRADIOL; FEMALE; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; INSULIN; LEUKOCYTES, MONONUCLEAR; PROGESTERONE; RATS; RATS, WISTAR; RECEPTORS, IMMUNOLOGIC; RECEPTORS, SCAVENGER; TESTOSTERONE;

EID: 84884197676     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-13-0175     Document Type: Article

References (27)

1. de Assis AM, Rieger DK, Longoni A, Battu C, Raymundi S, da Rocha RF, Andreazza AC, Farina M, Rotta LN, Gottfried C et al. 2009 High fat and highly thermolyzed fat diets promote insulin resistance and increase DNA damage in rats. Experimental Biology and Medicine 234 1296-1304. (doi:10.3181/0904-RM-126)
2. Cai W, He JC, Zhu L, Chen X, Wallenstein S, Striker GE & Vlassara H 2007 Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression. American Journal of Pathology 170 1893-1902. (doi:10.2353/ajpath.2007.061281)
3. Cai W, He JC, Zhu L, Chen X, Zheng F, Striker GE, & Vlassara H 2008 Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. American Journal of Pathology 173 327-336. (doi:10.2353/ajpath.2008.080152)
4. Cai W, Ramdas M, Zhu L, Chen X, Striker GE, & Vlassara H 2012 Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. PNAS 109 15888-15893. (doi:10.1073/pnas.1205847109)
5. Chatzigeorgiou AE, Lembessis PE, Mylona-Karagianni CF, Tsouvalas EA, Diamanti-Kandarakis E, & Kamper EF 2010 CD40 expression and its association with low-grade inflammation in a Greek population of type 1 diabetic juveniles: evidence for differences in CD40 mRNA isoforms expressed by peripheral blood mononuclear cells. Experimental and Clinical Endocrinology, & Diabetes 118 38-46. (doi:10.1055/s-0029- 1224151)
6. Diamanti-Kandarakis E, Piperi C, Kalofoutis A, & Creatsas G 2005 Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome. Clinical Endocrinology 62 37-43. (doi:10.1111/j.1365-2265.2004.02170.x)
7. Diamanti-Kandarakis E, Piperi C, Korkolopoulou P, Kandaraki E, Levidou G, Papalois A, Patsouris E, & Papavassiliou AG 2007a Accumulation of dietary glycotoxins in the reproductive system of normal female rats. Journal of Molecular Medicine 85 1413-1420. (doi:10.1007/s00109-007- 0246-6)
8. Diamanti-Kandarakis E, Piperi C, Patsouris E, Korkolopoulou P, Panidis D, Pawelczyk L, Papavassiliou AG, & Duleba AJ 2007b Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries. Histochemistry and Cell Biology 127 581-589. (doi:10.1007/s00418-006-0265-3)
9. Fukuhara-Takaki K, Sakai M, Sakamoto Y, Takeya M, & Horiuchi S 2005 Expression of class A scavenger receptor is enhanced by high glucose in vitro and under diabetic conditions in vivo: one mechanism for an increased rate of atherosclerosis in diabetes. Journal of Biological Chemistry 280 3355-3364. (doi:10.1074/jbc.M408715200)
10. Hsu HY, Nicholson AC, & Hajjar DP 1996 Inhibition of macrophage scavenger receptor activity by tumor necrosis factor-a is transcriptionally and post-transcriptionally regulated. Journal of Biological Chemistry 271 7767-7773. (doi:10.1074/jbc.271.13.7767)
11. Kandaraki E, Chatzigeorgiou A, Piperi C, Palioura E, Palimeri S, Korkolopoulou P, Koutsilieris M, & Papavassiliou AG 2012 Reduced ovarian glyoxalase-I activity by dietary glycotoxins and androgen excess: a causative link to polycystic ovarian syndrome. Molecular Medicine 18 1183-1189. (doi:10.2119/molmed.2012.00293)
12. Lam MC, Tan KC, & Lam KS 2004 Glycoxidized low-density lipoprotein regulates the expression of scavenger receptors in THP-1 macrophages. Atherosclerosis 177 313-320. (doi:10.1016/j.atherosclerosis.2004. 08.003)
13. Leuner B, Max M, Thamm K, Kausler C, Yakobus Y, Bierhaus A, Sel S, Hofmann B, Silber RE, Simm A et al. 2012 RAGE influences obesity in mice. Effects of the presence of RAGE on weight gain, AGE accumulation, and insulin levels in mice on a high fat diet. Zeitschrift für Gerontologie und Geriatrie 45 102-108. (doi:10.1007/s00391- 011-0279-x
14. Miura J, Uchigata Y, Yamamoto Y, Takeuchi M, Sakurai S, Watanabe T, Yonekura H, Yamagishi S, Makita Z, Sato A et al. 2004 AGE downregulation of monocyte RAGE expression and its association with diabetic complications in type 1 diabetes. Journal of Diabetes and its Complications 18 53-59. (doi:10.1016/S1056-8727(02)00281-7)
15. Miyazaki A, Nakayama H, & Horiuchi S 2002 Scavenger receptors that recognize advanced glycation end products. Trends in Cardiovascular Medicine 12 258-262. (doi:10.1016/S1050-1738(02)00171-8)
16. Mukhopadhyay S, & Mukherjee TK 2005 Bridging advanced glycation end product, receptor for advanced glycation end product and nitric oxide with hormonal replacement/estrogen therapy in healthy versus diabetic postmenopausal women: a perspective. Biochimica et Biophysica Acta 1745 145-155. (doi:10.1016/j.bbamcr.2005.03.010)
17. Murphy JE, Tedbury PR, Homer-Vanniasinkam S, Walker JH, & Ponnambalam S 2005 Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis 182 1-15. (doi:10.1016/j.atherosclerosis. 2005.03.036)
18. Nakamura K, Yamagishi SI, Matsui T, Adachi H, Takeuchi M, & Imaizumi T 2007 Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects. Clinical and Experimental Medicine 7 188-190. (doi:10.1007/s10238-007-0146-7)
19. NeyenC, Pluddemann A, Roversi P, Thomas B, Cai L, van derWesthuyzenDR, Sim RB, & Gordon S 2009 Macrophage scavenger receptor A mediates adhesion to apolipoproteins A-I and E. Biochemistry 48 11858-11871. (doi:10.1021/bi9013769)
20. Niwa T 2006 Mass spectrometry for the study of protein glycation in disease. Mass Spectrometry Reviews 25 713-723. (doi:10.1002/mas. 20089)
21. Rasband WS 1997-2004 ImageJ. Bethesda, Maryland, USA: National Institutes of Health. http://rsb.info.nih.gov/ij/.
22. Sourris KC, & Forbes JM 2009 Interactions between advanced glycation endproducts (AGE) and their receptors in the development and progression of diabeti. nephropathy - are these receptors valid therapeutic targets Current Drug Targets 10 42-50. doi:10.2174/138945019787122905
23. Sourris KC, Harcourt BE, Penfold SA, Yap FY, Morley AL, Morgan PE, Davies MJ, Baker ST, Jerums G, & Forbes JM 2010 Modulation of the cellular expression of circulating advanced glycation end-product receptors in type 2 diabetic nephropathy. Experimental Diabetes Research 2010 974681. (doi:10.1155/2010/974681)
24. Tan KC, Shiu SW, Chow WS, Leng L, Bucala R, & Betteridge DJ 2006 Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes. Diabetologia 49 2756-2762. (doi:10.1007/ s00125-006-0394-1)
25. Tan KC, Shiu SW, Wong Y, & Tam X 2011 Serum advanced glycation end products (AGEs) are associated with insulin resistance. Diabetes/Metabolism Research and Reviews 27 488-492. (doi:10.1002/dmrr.1188)
26. Tanaka N, Yonekura H, Yamagishi S, Fujimori H, Yamamoto Y, & Yamamoto H 2000 The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-a through nuclear factor-kB, and by 17b-estradiol through Sp-1 in human vascular endothelial cells. Journal of Biological Chemistry 275 25781-25790. (doi:10.1074/jbc.M001235200)
27. Uribarri J, Cai W, Ramdas M, Goodman S, Pyzik R, Chen X, Zhu L, Striker GE, & Vlassara H 2011 Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1. Diabetes Care 34 1610-1616. (doi:10.2337/dc11-0191)